118 related articles for article (PubMed ID: 10670406)
1. Assessing the effects of thyroid suppression on benign solitary thyroid nodules. A model for using quantitative research synthesis.
Csako G; Byrd D; Wesley RA; Sarlis NJ; Skarulis MC; Nieman LK; Pucino F
Medicine (Baltimore); 2000 Jan; 79(1):9-26. PubMed ID: 10670406
[TBL] [Abstract][Full Text] [Related]
2. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial.
Bennedbaek FN; Nielsen LK; Hegedüs L
J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis.
Richter B; Neises G; Clar C
Endocrinol Metab Clin North Am; 2002 Sep; 31(3):699-722. PubMed ID: 12227128
[TBL] [Abstract][Full Text] [Related]
4. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
[TBL] [Abstract][Full Text] [Related]
5. Thyroxine suppressive therapy in patients with nodular thyroid disease.
Gharib H; Mazzaferri EL
Ann Intern Med; 1998 Mar; 128(5):386-94. PubMed ID: 9490600
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis.
Castro MR; Caraballo PJ; Morris JC
J Clin Endocrinol Metab; 2002 Sep; 87(9):4154-9. PubMed ID: 12213864
[TBL] [Abstract][Full Text] [Related]
7. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics.
La Rosa GL; Ippolito AM; Lupo L; Cercabene G; Santonocito MG; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4385-7. PubMed ID: 8954046
[TBL] [Abstract][Full Text] [Related]
8. The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules -- a randomised, double-blind, placebo-controlled study.
Tsai CC; Pei D; Hung YJ; Wang TF; Tsai WC; Yao CY; Hsieh MC; Kuo SW
Int J Clin Pract; 2006 Jan; 60(1):23-6. PubMed ID: 16409424
[TBL] [Abstract][Full Text] [Related]
9. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M
J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459
[TBL] [Abstract][Full Text] [Related]
10. Is the effect of fine-needle aspiration biopsy on the thyroid nodule volume important to evaluate the effectiveness of suppression therapy?
Güney E; Ozgen AG; Kabalak T
J Endocrinol Invest; 2003 Jul; 26(7):651-4. PubMed ID: 14594117
[TBL] [Abstract][Full Text] [Related]
11. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women.
Costante G; Crocetti U; Schifino E; Ludovico O; Capula C; Nicotera M; Arturi F; Filetti S
J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240
[TBL] [Abstract][Full Text] [Related]
12. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
13. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.
Zelmanovitz F; Genro S; Gross JL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3881-5. PubMed ID: 9814462
[TBL] [Abstract][Full Text] [Related]
14. Changes in the thyroid technetium-99m scintigram after antithyroid and subsequent radioiodine treatment for solitary autonomous nodules.
Nygaard B
Thyroid; 1998 Mar; 8(3):223-7. PubMed ID: 9545108
[TBL] [Abstract][Full Text] [Related]
15. [Suppressive hormone therapy for thyroid nodules. Prospective evaluation. Preliminary results].
Wémeau JL; Cousty C; Vlaeminck V
Ann Endocrinol (Paris); 2000 May; 61(2):119-24. PubMed ID: 10891662
[TBL] [Abstract][Full Text] [Related]
16. [Levothyroxine treatment of the solitary thyroid nodule].
Almodóvar Ruiz F; Maldonado Castro G; de Luis D; Lahera M; Varela da Costa C
An Med Interna; 2000 Feb; 17(2):99-101. PubMed ID: 10829467
[TBL] [Abstract][Full Text] [Related]
17. Thyroid-hormone-suppressive therapy in benign thyroid nodules.
Helling TJ
Lancet; 2003 Mar; 361(9363):1137. PubMed ID: 12672348
[No Abstract] [Full Text] [Related]
18. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials.
Sdano MT; Falciglia M; Welge JA; Steward DL
Otolaryngol Head Neck Surg; 2005 Sep; 133(3):391-6. PubMed ID: 16143188
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
[TBL] [Abstract][Full Text] [Related]
20. Levothyroxine suppressive therapy for solitary thyroid nodule.
Mainini E; Martinelli I; Morandi G; Villa S; Stefani I; Mazzi C
J Endocrinol Invest; 1995 Nov; 18(10):796-9. PubMed ID: 8787957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
